Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Iron deficiency may be related to hair loss, but there's not enough evidence to recommend iron screening or supplements for all hair loss patients.

Male and female skin differ in many ways, which could lead to gender-specific skin treatments.

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

Different animals have unique versions of the enzyme that changes testosterone into another hormone, which is important for creating effective treatments for prostate and hair loss conditions.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Laser device increases hair density, safe for treating hair loss in men and women.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Nanoparticles can improve skin drug delivery but have challenges like toxicity and stability that need more research.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Hair loss in men treated best with early medication or transplant, new treatments researched.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

Alpha-hydroxy acids, like glycolic acid, safely improve skin issues and work on all skin types.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

The document concludes that minoxidil and finasteride are proven for hair growth, herbal remedies show promise, but more research is needed to confirm their effectiveness.

Correcting nutrient deficiencies may help with hair loss, but the benefits of supplements without a deficiency are uncertain and could be harmful.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Some common medications can harm male fertility, but many effects can be reversed.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Many people with alopecia experience high levels of social anxiety, anxiety, and depression, and while wigs can boost confidence, they may also cause anxiety.

Low-dose finasteride may cause lasting sexual dysfunction and suicidal thoughts in young men.